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Abstract
Systemic lupus erythematosus (SLE) is characterized by multiple cellular abnormalities culminating in the production of
autoantibodies and immune complexes, resulting in tissue inflammation and organ damage. Besides active disease, the
main cause of morbidity and mortality in SLE patients is infections, including those from opportunistic pathogens. To
understand the failure of the immune system to fend off infections in systemic autoimmunity, we infected the lupus-prone
murine strains B6.lpr and BXSB with the intracellular parasite Toxoplasma gondii and survival was monitored. Furthermore,
mice were sacrificed days post infection and parasite burden and cellular immune responses such as cytokine production
and cell activation were assessed. Mice from both strains succumbed to infection acutely and we observed greater
susceptibility to infection in older mice. Increased parasite burden and a defective antigen-specific IFN-gamma response
were observed in the lupus-prone mice. Furthermore, T cell:dendritic cell co-cultures established the presence of an intrinsic
T cell defect responsible for the decreased antigen-specific response. An antigen-specific defect in IFN- gamma production
prevents lupus-prone mice from clearing infection effectively. This study reveals the first cellular insight into the origin of
increased susceptibility to infections in SLE disease and may guide therapeutic approaches.
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Introduction
Systemic lupus erythematosus (SLE) is a debilitating disease,
primarily affecting women, and presents with manifestations in
most organs [1]. Aside from active disease, infections represent the
major cause of morbidity and mortality [2,3]. In fact, it has been
reported 20–55% of all deaths of SLE patients result from
infections [3]. Notwithstanding the fact that immunosuppressive
drugs, routinely used in the treatment of patients with SLE,
contribute to the increased rates of infections, inherent defects in
the innate and acquired immune responses play an important role
in susceptibility. For example, although T cells provide excessive
help to B cells to produce autoantibodies, they are unable to raise
proper cytotoxic responses [4] and they produce decreased levels
of IL-2 [5]. Furthermore, autoantibodies against various cell
components likely contribute to the increased incidence of
infection in these patients [6,7]. The mechanism of increased
susceptibility to infection by SLE patients has not been well
examined and this paper begins to unravel this phenomenon.
In addition to common infections, patients with SLE suffer from
infections with opportunistic pathogens such as Listeria monocy-
togenes, Cryptococcus neoformans, Pneumocystis carinii and
Toxoplasma gondii [8]. T. gondii is an intracellular parasite that
often results in asymptomatic infection in healthy individuals as
the parasite develops strategies to coexist with host cells [9].
Immunity to T. gondii is driven by IFN-gamma production [10].
SLE patients have higher titers of antibodies against T. gondii as
compared to healthy controls [11] and a diagnosis of toxoplas-
mosis can easily be missed as the symptoms are similar to that of
lupus cerebritis [12]. As with other CNS infections in SLE
patients, T. gondii presents difficult diagnostic and therapeutic
decisions.
To better understand the proclivity of SLE patients to suffer
infections, we infected lupus-prone mice with T. gondii. Because
individual lupus-prone murine strains do not epitomize the full
spectrum of human disease, we infected two genetically-diverse
lupus-prone murine strains (B6.lpr, BXSB) with this parasite and
observed survival as well as elements of the cellular immune
response. We report here that lupus-prone mice succumbed
during the acute stage of infection due to increased parasite
burden, independent of elevated systemic IFN-gamma levels in the
serum. We found that T. gondii-infected mice display a severely
depressed antigen-specific T cell IFN-gamma response that likely
accounts for the increased mortality. This information sheds new
light on the origin of increased susceptibility to infections in
systemic autoimmunity and suggests the need for new approaches
to mitigate infection-related morbidity and mortality.
Materials and Methods
Mice
Two strains of lupus-prone mice and appropriate controls were
purchased for these studies. Female C57BL/6 mice were age and
sex matched with B6.lpr mice and the lupus-prone male BXSB
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Laboratories, Bar Harbor, ME). Mice were randomly assigned to
control or experimental group. Three to six mice per group were
used for each experiment and replicated multiple times as
indicated in the figure legend. CBA (Jackson Laboratories, Bar
Harbor, ME) and Swiss Webster (Taconic, Germantown, NY)
mice were used for in vivo maintenance of parasites. Mice were
group housed in the barrier facility in the Center for Life Science
at Beth Israel Deaconess Medical Center with a twelve-hour light/
dark cycle.
Parasites
The Me49 strain of T. gondii was used for these studies (ATCC,
Manassas, VA). Parasites were maintained and passaged in vivo in
Swiss Webster or CBA mice. Parasites were also maintained
in vitro in HS27 human foreskin fibroblast cells (ATCC,
Manassas, VA). Parasites were prepared from mouse brain isolates
and diluted in phosphate buffered saline for injections.
Survival Curves
Lupus-prone mice and appropriate controls were infected
intraperitoneally with the Me49 strain of T. gondii. Infected mice
were monitored daily for signs of lethargy, ruffling, and abnormal
ambulation. If mice displayed any one of these criteria, they were
then monitored twice daily. Mice were sacrificed by gas cylinder
CO2 when they became moribund and that day post infection was
considered the survival endpoint.
ELISA, serum collection, urine collection, antibody
treatment
Splenocytes from infected animals were stimulated in vitro with
5 ng/ml of IL-12 or 20 ug/ml of STAg for 72 h and supernatants
were assayed for IFN-gamma by ELISA (eBiosciences, San Diego,
CA). IFN-gamma and other cytokines were measured from serum
collected from the tail vein by a multiplex bead assay (Bio-Rad,
Hercules, CA). Anti-dsDNA was measured by ELISA from murine
serum monthly to assess autoimmune status (Alpha Diagnostic
International, San Antonio, TX). Urine was collected overnight in
metabolic cages once a month and proteinuria was measured to
monitor lupus-disease progression. Anti-PD-L1 (gift from Gordon
Freeman Dana Farber Research Institute, Boston, MA) was
administered intraperitoneally at 200 mg starting at day 21 before
infection and every third day thereafter.
Flow cytometry
Splenocytes or peritoneal exudate cells were surface stained with
the following markers (CD3, CD4, CD8, NK1.1, B220, CD5,
CD11-b, GR-1, CD11c, F4/80, IA/IE, H-2k, CD44, CD62L,
CD80, CD86, PD-1, PD-L1, Tim-3, Ly6G, CD21, CD23, CD38,
CD25, Fas, FoxP3; Biolegend, San Diego, CA) and cells were
collected on an LSRII flow cytometer (Becton Dickinson, CA).
Data was analyzed using FlowJo software (Treestar, Ashland, OR).
Recall response
Spleens were removed from mice following sacrifice 7 days
post-infection. Splenocytes were isolated and plated at 4 6 10
5
cells/well in 96 well plates. Cells were stimulated with the parasite
antigen STAg and/or IL-12 for 72 hours. STAg was prepared as
previously described [13]. IFN-gamma production was measured
by ELISA.
Non-specific TCR stimulation
CD3
+ T cells were purified from spleens of naı ¨ve B6.lpr and
BXSB mice by negative selection (Pan T cell isolation kit II,
Miltenyi, Auburn, CA) and stimulated with anti-CD3 (0.5ug/ml;
eBiosceinces) and anti-CD28 (1 ug/ml; Biolegend) for 3 days.
Supernatants were assayed for IFN-gamma production by ELISA.
Parasite Burden
Cells were collected by peritoneal lavage with 5 ml cold PBS
following the sacrifice of the mice and cytospins were prepared to
determine parasite burden. Slides were stained with Hema3 Stain
(Biochemical Sciences, Swedesboro, NJ) and sealed with mounting
medium (Richard Allan Scientific, Kalamazoo, MI). Parasite
burden was assessed by counting a minimum of 500 cells per
cytospin in a blinded manner.
T cell:DC mixing experiment
Lupus-prone and control mice were infected with T. gondii and
7 days later spleens were removed and splenocytes were prepared.
CD11c
+ cells were isolated by magnetic separation using positive
selection (CD11c
+ isolation kit, Miltenyi, Auburn, CA). The flow-
through was collected and CD3
+ cells were isolated by negative
selection from the same animal (Pan T cell isolation kit II,
Miltenyi, Auburn, CA). Cells were plated in 96 well plates at a
ratio of 5 T cells to 1 dendritic cell (T-3610
5: DC-6610
4). Antigen
was added to the wells (STAg 20 ug/ml) and the plate was
incubated for 72 hours at 37uC, 5% CO2. Supernatants were
assayed for IFN-gamma production by ELISA (eBioscience, San
Diego, CA).
Statistical analysis
Unpaired two-tailed Student t tests were calculated using
PRISM software (GraphPad). A p value of ,0.05 was considered
significant.
Ethics Statement
All murine work was reviewed and approved by the IACUC at
Beth Israel Deaconess Medical Center. Beth Israel Deaconess
Medical Center is AAALAC accredited and complies with all
federal, state, and local laws. These studies were carried out under
IACUC protocols 101–2009 and 069–2012.
Results
Lupus-prone mice are susceptible to infection with T.
gondii
We used a model of T. gondii infection to investigate whether
inherent immune dysfunction in lupus-prone mice leads to
increased susceptibility to infection. Because none of the
commonly used lupus-prone murine strains perfectly mimic
human SLE disease, we decided to study two different mouse
strains. The mice we chose to investigate were B6.lpr (mutated
lymphoproliferation (lpr) gene), and the BXSB strain (male mice
have the Y chromosome linked autoimmune accelerator gene
(Yaa)). The B6.lpr mice are defective in Fas-mediated signaling
[14], while the BXSB mice overexpress Tlr7 [15]. The onset of
lupus disease in these mice occurs at different time points,
therefore we infected mice 1–3 months before the onset of the
disease to ensure that the results would not be complicated by
immune abnormalities and organ damage imposed by disease
activity. Accordingly, the mice studied had increased levels of anti-
dsDNA antibodies but they had not yet developed proteinuria.
Defective Antigen-Specific Response in Lupus-Prone Mice
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20 weeks of age as they displayed a significant increase in
circulating anti-dsDNA antibodies as compared to wild type
controls, but they did not exhibit any proteinuria. Similarly, BXSB
mice were infected at 14 weeks of age. We found that although
they are genetically different, both SLE-prone mice rapidly
succumbed to acute infection within twelve days post-infection
(Figure 1A). This differs from previously published data in which
NZBWF1 mice were orally infected with T. gondii, resulting in a
chronic infection [16]. This variance may have to do with the
different genetic background of those mice and/or the route of
infection as peroral infection often results in chronic disease.
Additionally, we infected younger mice to determine whether
susceptibility to infection is affected by age as mice develop more
autoimmune manifestations with age. B6.lpr mice were infected at
14 weeks of age and BXSB mice were infected at 8 weeks of age.
We found that mice expressing lower levels of anti-dsDNA
(therefore less autoimmunity) were less susceptible to infection
compared to older mice suggesting immunosuppression increases
with disease progression (Figure 1B). All of the following studies
were conducted on B6.lpr mice at 20 weeks of age and BXSB mice
at 14 weeks of age.
Lupus-prone mice display an increased parasite burden
following infection
Previous studies have established that many immunocompro-
mised mice succumb to acute T. gondii infection when they are
unable to control parasite replication, an event linked to defects in
cytokine production or function. We measured parasite burden in
the peritoneum of infected mice and in B6.lpr we found a
significantly higher parasite burden in mice 9 days post infection
(p=0.001) (Figure 2A). An increased parasite burden was
observed 7 days post infection in the BXSB mice (p,0.0001)
(Figure 2B). These data indicate that lupus-prone mice are unable
to effectively control parasite replication.
Systemic IFN-gamma does not sufficiently protect
against T. gondii infection
The major route of resistance to T. gondii infection is IL-12
driven IFN-gamma production. Increased parasite burden is often
associated with decreased IFN-gamma production [17]. We
examined serum cytokine levels at the peak of IFN-gamma
production, 7 days after infection, and found no significant
difference in the systemic levels of IFN-gamma in B6.lpr mice
(Figure 3A). In fact, the levels of IFN-gamma in the B6.lpr mice
after infection tended to be higher than that of wild type mice,
though this difference did not reach significance. Conversely, IFN-
gamma levels in BXSB mice were significantly decreased
Figure 1. Lupus-prone mice succumb to acute infection with T. gondii. (A) Two strains of SLE-prone mice exhibiting exacerbated
autoimmune markers but no lupus pathology were infected with 20 Me49 i.p. and survival was monitored. B6.lpr mice were age and sex matched
with C57BL/6 mice. Male BXSB mice were age-matched with females of the colony who do not develop lupus-like disease. All lupus-prone mice
succumbed to infection within the first 12 days of infection. (B) Younger mice were infected for the above strains and it was observed that they had
increased survival. Each survival curve represents at least two replicates of 3–6 mice per group.
doi:10.1371/journal.pone.0111382.g001
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we found no defect in systemic IL-12 (data not shown).
T cell antigen specific IFN-gamma production is
decreased in lupus-prone mice following T. gondii
infection
We examined activation markers on various cell types from the
spleen and the peritoneum of infected (and uninfected) lupus-
prone mice but found no significant differences in distribution or
activation markers as compared to wild type mice (data not
shown). Since T cell activation appeared normal as evidenced by
no significant differences in the percentage of CD3
+CD4
+
CD44
hiCD62L
lo or CD3
+CD8
+CD44
hiCD62L
lo cells, we asked
whether T cells from lupus-prone mice were functionally
competent. To address this question, we assessed the ability of
these cells to respond to specific antigen stimulation. We
stimulated splenocytes from infected mice with T. gondii-specific
antigen (STAg) for 3 days in vitro and measured IFN-gamma
production in the culture supernatants. We found that cells from
infected B6.lpr (Figure 4A) and BXSB mice (Figure 4B) produced
greatly reduced levels of antigen-specific IFN-gamma indicating a
defective antigen recall response.
To ensure that this response was indeed antigen specific and not
due to a non-specific T cell defect in these mice, CD3
+ T cells were
purified from spleens of naı ¨ve B6.lpr and BXSB mice and
stimulated with anti-CD3 and anti-CD28 for 3 days. Supernatants
were assayed for IFN-gamma production and we did not find any
defect in the ability of these cells to respond to non-specific TCR
stimuli (Figure 5). In fact, in both B6.lpr and BXSB mice, we
observed an increased IFN-gamma response as compared to the
wild type controls. Similarly, an increased IFN-gamma response
has been reported following TCR stimulation of peripheral T cells
from SLE patients [18].
An intrinsic T cell defect leads to decreased antigen-
specific response
The decreased antigen-specific response observed in lupus-
prone mice is due to decreased IFN-gamma production by T cells.
To investigate whether this is due to an intrinsic T cell defect or
the result of defective antigen presentation, we purified T cells and
dendritic cells (DCs) from spleens of infected wild type or lupus-
prone mice and mixed them in vitro in the presence or absence of
T. gondii antigen. There was a baseline level of IFN-gamma
produced in the absence of STAg (Figure 6 lower portion) and this
is to be expected since the parasite is present in the splenocyte
cultures isolated from infected animals. We found that T cells from
lupus-prone mice mixed with DCs from wild type mice produced
less IFN-gamma as compared to wild type T cells mixed with DCs
from lupus-prone mice which produced similar levels of IFN-
gamma as wild type T cells mixed with wild type DCs (Figure 6
Figure 2. Parasite burden is increased in lupus-prone mice.
Mice were sacrificed 7–10 days following infection and peritoneal
lavage was performed. A cytospin was prepared from each mouse and
then the percent of infected cells was quantified. (A) B6.lpr mice
showed a significant increase in parasite burden 9 dpi. (B) BXSB mice
had significantly increased parasite burden 7 dpi. Each experiment was
carried out 2–3 times with 3–6 mice per group.
doi:10.1371/journal.pone.0111382.g002
Figure 3. Systemic IFN-gamma does not sufficiently protect
lupus-prone mice. IFN-gamma levels were measured in the serum of
lupus-prone mice 7 days post infection (dpi) by multiplex. No
significant differences were found between infected B6.lpr mice and
infected WT controls (A). BXSB mice had reduced levels of systemic IFN-
gamma (B). B6.lpr mice were 20 weeks of age and BXSB mice were 14
weeks of age. Each experiment was carried out at least 3 times with 3–6
mice per group.
doi:10.1371/journal.pone.0111382.g003
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is intact in the lupus-prone mice, but these mice harbor an
intrinsic T cell defect leading to decreased IFN-gamma produc-
tion.
Discussion
One of the leading causes of morbidity and mortality in SLE
patients is infection. It is well known that the immune system of
SLE patients is dysregulated but there has been little insight as to
how it responds to challenge with infectious organisms. The use of
steroids and other immunosuppressive drugs in SLE patients
complicates the ability to separate the effects of the drugs from the
natural dysregulation of the immune response triggered by disease.
Lupus-prone mice allow us to parse the immune response to
infectious agents in the context of autoimmunity. We show in this
study that lupus-prone mice display increased susceptibility to
infection which is accentuated as disease progresses. To our
surprise, lupus-prone mice succumbed acutely to infection with the
prototypic Th1-inducing pathogen T. gondii; this occurred in both
B6.lpr mice and BXSB mice. We observed decreased systemic
IFN-gamma production in the BXSB mice therefore it was not
surprising that there was a decreased ability to control parasite
burden as it has been well established that IFN-gamma is
necessary for control of this parasite. Furthermore, it has
previously been reported that BXSB mice are susceptible to acute
infection with the intracellular parasite Trypanosoma cruzi [19].
Conversely, the B6.lpr mice did not have decreased systemic IFN-
gamma, therefore the dichotomy between the increased levels of
IFN-gamma in the serum of B6.lpr mice following infection
(similar to what is seen in wild type mice), and the inability to
Figure 4. Antigen-specific response is defective in lupus-prone mice. Splenocytes were collected from infected mice 7 dpi and were
stimulated 3 days in vitro with either IL-12 (5ng/ml), STAg (20 ug/ml), or IL-12+ STAg. Supernatants were assayed by ELISA for IFN-gamma
production. A significant decrease in antigen-specific IFN-gamma was observed (*). (A) B6.lpr (B) BXSB. B6.lpr mice were 20 weeks of age and BXSB
mice were 14 weeks of age. This experiment is representative of 2–3 individual experiments with 3–4 mice per group.
doi:10.1371/journal.pone.0111382.g004
Figure 5. TCR-stimulation is not defective in lupus-prone mice.
T cells were isolated from splenocytes of either B6.lpr or BXSB mice and
the appropriate controls. Cells were stimulated with anti-CD3/anti-CD28
for 72 hours and supernatants were assayed for IFN-gamma production
by ELISA. The IFN-gamma response to non-specific TCR stimulation was
intact in these mice. B6.lpr mice were 20 weeks of age and BXSB mice
were 14 weeks of age. This experiment is representative of two
individual experiments.
doi:10.1371/journal.pone.0111382.g005
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explained by considering the sources of IFN-gamma during T.
gondii infection. During early infection, systemic IFN-gamma
comes from multiple cellular sources with NK cells being a major
producer of IFN-gamma. While this IFN-gamma will be
protective, it does not provide sufficient protection for the mice
to survive beyond acute infection (approximately two weeks in wild
type mice) [20]. Antigen-specific IFN-gamma production from T
cells is necessary for protection against this pathogen [21].
Interestingly, patients with SLE are susceptible to infection with
other Th1 pathogens such as Salmonella spp. [6] though they have
elevated levels of IFN-gamma [22,23]. This may be explained by a
decreased ability of IFN-gamma to bind the IFN-gamma receptor
or perhaps a defect in signaling through this receptor. It has been
reported by one group that polymorphisms in the IFN-gammaR
may increase the likelihood of SLE development and it has been
shown that these polymorphisms can lead to an alteration in
receptor function, resulting in a decreased response to IFN-gamma
[24,25]. Conversely, another group concluded these polymor-
phisms are not associated with SLE in a different patient
population [26].
The significantly decreased production of antigen-specific IFN-
gamma in response to infection was unexpected. The expression of
autoimmunity has been found to be dependent on the presence of
IFN-gamma particularly during late stages of disease. Elevated
IFN-gamma levels contribute to tissue damage and it has been
reported that lupus-prone mice in which IFN-gamma or IFN-
gammaR has been deleted display reduced disease and mortality
[27]. From our studies, it appears that non-specific IFN-gamma
production found in lupus-prone mice is not sufficient to provide
defense against infectious agents; survival may depend on antigen-
specific IFN-gamma. As shown in Figure 1B, mice that have not
yet developed significant autoimmunity survive longer than mice
that have established autoimmune disease. We questioned if this
increased protection was reliant on antigen-specific IFN-gamma
production. Interestingly, recall responses from splenocytes of
infected 14-week old B6.lpr mice or 8-week old BXSB mice
displayed no defect in antigen specific IFN-gamma production
(data not shown) suggesting this T cell function is integral to a
successful immune response to T. gondii.
Upon observation that IFN-gamma was decreased in recall
cultures, we wanted to know if this was due to a defect in antigen
presentation or if it was a result of T cell dysfunction. We found
that T cells are directly responsible for the defect in antigen
specific IFN-gamma production as T:DC co-cultures revealed that
antigen presentation is intact in these lupus-prone mice. Studies
from our group and others have identified various defects in T cell
signaling in SLE T cells and this may contribute in part to the
observations made in these studies [28]. It should be considered
that though the same number of T cells were added to the mixing
cultures from either wild type or lupus-prone mice, the ratio of
parasite-specific cells to other T cells present may be different
between mouse strains. The lupus-prone mice may not increase
their number of T. gondii-specific T cells as robustly as wild type
Figure 6. An intrinsic T cell defect is responsible for the decrease in antigen-specific IFN-gamma production. CD3
+ T cells and CD11c
+
DCs were isolated from splenocytes of infected mice 7 dpi. Cells were mixed at a ratio of 5:1 (T:DC) and incubated for 72 hours +/2 STAg. IFN-gamma
was measured from supernatants by ELISA. (A) B6.lpr; (B) BXSB; each assay was performed 3 times in triplicate. B6.lpr mice were 20 weeks of age and
BXSB mice were 14 weeks of age.
doi:10.1371/journal.pone.0111382.g006
Defective Antigen-Specific Response in Lupus-Prone Mice
PLOS ONE | www.plosone.org 6 October 2014 | Volume 9 | Issue 10 | e111382mice. New tools may allow us to identify the percentage of
antigen-specific T cell clones in the future.
During this study we found that lupus-prone mice trended
towards increased expression of PD-1 on CD4
+ T cells from
infected mice as compared to T cells from infected wild type mice
(data not shown). We considered that T cells had become
refractive to stimulation due to the increased levels of PD-1, a
molecule known to be upregulated on functionally exhausted T
cells [29]. Furthermore, it has been reported that the PD-1:PD-L1
pathway plays a role in inhibiting the functionality of CD8
+ T cells
during chronic T. gondii infection [30]. We indirectly blocked PD-
1 signaling by injecting anti-PD-L1 into B6.lpr mice prior to and
following infection with T. gondii. Though it has been reported
that infecting PD-L1
2/2 mice results in better outcomes for some
infections, we found that blocking PD-L1 did not affect survival of
lupus-prone mice. Similarly, it has been reported that blocking
PD-L1 during acute L. monocytogenes infection does not enhance
the immune response [31]. We concluded that the defect we
observed in the lupus-prone mice was not likely due to functional
exhaustion, though it should be noted that we did not block
secondary ligands to PD-1, such as PD-L2 or PD-L3.
Our data present novel insight into the cellular immune events
that account for increased susceptibility of lupus-prone mice to
infection. At the translational level, our data suggest that in
addition to antibiotics, the correction of failing T cell function in
SLE patients should produce more favorable clinical outcomes
following infections.
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